Exploration of the in-vitro pharmacodynamic activity of moxifloxacin for Staphylococcus aureus and Streptococci of lancefield groups A and G.
about
In vitro models, in vivo models, and pharmacokinetics: what can we learn from in vitro models?Bactericidal activities of methoxyfluoroquinolones gatifloxacin and moxifloxacin against aerobic and anaerobic respiratory pathogens in serum.Pharmacodynamics of gemifloxacin against Streptococcus pneumoniae in an in vitro pharmacokinetic model of infection.Discrepancy between uptake and intracellular activity of moxifloxacin in a Staphylococcus aureus-human THP-1 monocytic cell modelActivities of ciprofloxacin and moxifloxacin against Stenotrophomonas maltophilia and emergence of resistant mutants in an in vitro pharmacokinetic-pharmacodynamic model.Activity of gatifloxacin in an in vitro pharmacokinetic-pharmacodynamic model against Staphylococcus aureus strains either susceptible to ciprofloxacin or exhibiting various levels and mechanisms of ciprofloxacin resistance.
P2860
Exploration of the in-vitro pharmacodynamic activity of moxifloxacin for Staphylococcus aureus and Streptococci of lancefield groups A and G.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Exploration of the in-vitro ph ...... of lancefield groups A and G.
@en
Exploration of the in-vitro ph ...... of lancefield groups A and G.
@nl
type
label
Exploration of the in-vitro ph ...... of lancefield groups A and G.
@en
Exploration of the in-vitro ph ...... of lancefield groups A and G.
@nl
prefLabel
Exploration of the in-vitro ph ...... of lancefield groups A and G.
@en
Exploration of the in-vitro ph ...... of lancefield groups A and G.
@nl
P2093
P356
P1476
Exploration of the in-vitro ph ...... of lancefield groups A and G.
@en
P2093
P304
P356
10.1093/JAC/44.6.761
P407
P577
1999-12-01T00:00:00Z